Patents by Inventor Jian Ding

Jian Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220389025
    Abstract: Provided are a heterocyclic amide compound of general formula (I), a pharmaceutically acceptable salt thereof and a preparation method therefor, and the use of the compound in the preparation of a drug for treating diseases related to the activity of STING, in the preparation of an immunologic adjuvant, and in the preparation of a drug for activating STING.
    Type: Application
    Filed: September 21, 2020
    Publication date: December 8, 2022
    Inventors: Wenhu DUAN, Meiyu GENG, Huibin ZHANG, Zuoquan XIE, Jinpei ZHOU, Yifei YANG, Xiyuan WANG, Xiaojun YANG, Yan ZHANG, Zhaoxue HU, Jian DING
  • Publication number: 20220382477
    Abstract: A computing device, a method, and a computer readable medium for transferring data objects predictively to reduce consumption of resources. In some embodiments, a computing device includes: a memory; and a processor coupled to the memory. The processor is configured to store data objects in a storage system. The storage system is a multi-tier storage system. Storage of the data objects includes: determining a future demand status for at least one data object stored in the storage system based on a set of access activity rules; and moving the at least one data object between tiers of the storage system in response to the determined future demand status being different from a current demand status of the at least one data object to reduce consumption of resources in which to store that data object.
    Type: Application
    Filed: May 26, 2021
    Publication date: December 1, 2022
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang, Feng Tao
  • Publication number: 20220373445
    Abstract: The present disclosure provides an experimental device for simulating the erosion of a tubing string caused by sand production. The experimental device includes an autoclave, a circulating assembly, a power assembly, a monitoring assembly, or a three-phase feeding assembly. The circulating assembly is sealed and arranged in the autoclave, the circulating assembly includes a circulation loop formed by straight pipes and elbows. The power assembly includes a pump arranged on the circulation loop. The monitoring assembly includes a flowmeter and a temperature and pressure sensor for detecting the circulation loop, and the temperature and pressure sensor is communicatively connected with a PC. The three-phase feeding assembly includes a feeding pipe that is in fluid communication with the circulation loop, and the feeding pipe is connected with one or more gas tanks, a sander feeder, and one or more liquid tanks, respectively.
    Type: Application
    Filed: January 25, 2022
    Publication date: November 24, 2022
    Applicant: SOUTHWEST PETROLEUM UNIVERSITY
    Inventors: Zhi ZHANG, Jie YANG, You WU, Jian DING, Jiawei WANG
  • Publication number: 20220356202
    Abstract: The present invention relates to a mannuronic diacid oligosaccharide composition, comprising a mannuronic diacid of Formula (III) or a pharmaceutically acceptable salt thereof, wherein n is an integer from 1 to 9, m is 0, 1 or 2, and m? is 0 or 1, and wherein the total weight of mannuronic diacids wherein n=1-5 is 80-95% of the total weight of the composition, and the ratio of the total weight of mannuronic diacids wherein n=1-3 to the total weight of mannuronic diacids wherein n=4-7 is between 1.0 and 3.5.
    Type: Application
    Filed: July 8, 2022
    Publication date: November 10, 2022
    Inventors: Meiyu Geng, Jian Ding, Zhenqing Zhang, Zhongping Xiao, Xiaoguang Du, Xianliang Xin
  • Patent number: 11487398
    Abstract: A computing device may include a display, and a processor coupled to the display and configured to generate a GUI current screen on the display. The GUI current screen may include a first window and a second window docked to the first window, the second window overlapping the first window. The processor may be configured to determine an interaction region in the first window based upon user input in the first window, determine a ratio of overlap between the first window and the second window, and resize the second window based upon the ratio of overlap and so that the second window does not overlap the interaction region.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: November 1, 2022
    Assignee: CITRIX SYSTEMS, INC.
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang, Yanjun Su
  • Patent number: 11481231
    Abstract: The systems and methods discussed herein provide for intelligent identification of applications or tasks to be utilized or performed by a user based on a variety of variables that provide relevant context. In some implementations, applications may be pre-launched or instantiated prior to a user requesting to execute the application, reducing user experience latency and avoiding incorrect application launch. User behavior patterns, location, time of day, user events, etc. may be utilized to identify and recommend or pre-launch relevant applications that should or can be used at any given instance. In some implementations, deep linking may be used to pre-launch or suggest specific tasks to be performed within an application.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: October 25, 2022
    Assignee: Citrix Systems, Inc.
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang, Jian Piao, Jinping Liu, Divyansh Deora, Arnav Akhoury, Nandikotkur Achyuth
  • Publication number: 20220324869
    Abstract: A compound having Axl and c-Met kinase inhibitory activity, a preparation method therefor and an application thereof are provided. Specifically, provided herein are a compound having the structure represented by formula (I), a preparation method therefor and an application thereof in the preparation of a medication for the treatment and/or prevention of tumor-associated diseases and/or kinase-related diseases.
    Type: Application
    Filed: September 3, 2020
    Publication date: October 13, 2022
    Inventors: Wenhu DUAN, Meiyu GENG, Hefeng ZHANG, Jian DING, Jing AI, Xia PENG, Yinchun JI
  • Patent number: 11465984
    Abstract: The invention relates to a compound of formula (I): wherein variables are as defined in the specification. The compound is an inhibitor of an ERK kinase, e.g. ERK1 and/or ERK2 kinase. The invention also relates to the use of the compound and a method for preparing the compound, and a pharmaceutical composition containing the compound.
    Type: Grant
    Filed: September 29, 2018
    Date of Patent: October 11, 2022
    Assignees: SHANGHAI HAIHE PHARMACEUTICAL CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Lei Li, Meiyu Geng, Ying Huang, Jian Ding, Qiong Zhang, Min Huang, Shuai Tang, Ning Shen, Yi Chen
  • Patent number: 11464826
    Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: October 11, 2022
    Inventors: Qing Qi, Jian Ding
  • Patent number: 11464794
    Abstract: The present invention relates to an alginic oligosaccharic diacid composition comprising a mannuronic diacid of Formula (IV) or a pharmaceutically acceptable salt thereof, wherein n is an integer selected from 1 to 9, m is selected from 0, 1 or 2, m? is selected from 0 or 1, and wherein the total weight of alginic oligosaccharic diacid wherein n=1-5 accounts for more than 60% of the total weight of the composition; the total weight of guluronic acids accounts for less than 50% of the total weight of the composition.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 11, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Zhenqing Zhang, Yingshen Jin, Zhongping Xiao, Jian Ding
  • Publication number: 20220315582
    Abstract: The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.
    Type: Application
    Filed: July 31, 2020
    Publication date: October 6, 2022
    Inventors: Chris ADAIR, Tracy CHEN, Jian DING, Christy FRYER, Yuko ISOME, Marie-Helene LARRAUFIE, Katsumasa NAKAJIMA, Nik SAVAGE, Ariel Sterling TWOMEY
  • Patent number: 11455227
    Abstract: Methods and systems for determining information of applications are described herein. A computing device may receive, from one or more client devices, data indicating application usage events. The computing device may determine, based on the data, popular applications that a target user regularly uses. The computing device may determine, based on the data, recommended applications that users similar to the target user regularly use. The computing device may determine, based on the popular applications and/or the recommended applications, a collection of applications for the target user. The collection of applications may be displayed on a user interface of a client device associated with the target user for expedited access of interested applications.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: September 27, 2022
    Assignee: Citrix Systems, Inc.
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang
  • Publication number: 20220300540
    Abstract: Disclosed herein are embodiments of systems, methods, and products comprising a data power server for secure storage and retrieval of trade data. The server receives a request from a user to review or confirm one or more trade documents via a webserver. The server communicates with a connector grid server to retrieve the user's accessible documents. The connector grid server determines the electronic file IDs that are accessible to the user based on the accessibility policy. The server instructs a digital library server to download the electronic files containing the requested trade data. The digital library server retrieves and downloads the electronic files based on the file IDs. The webserver renders a GUI displaying the electronic files on an electronic client device operated by the user. Upon receiving the confirmation response from the user, the server instructs the digital library server to update the trade status.
    Type: Application
    Filed: June 7, 2022
    Publication date: September 22, 2022
    Applicant: Bank of Montreal
    Inventor: Jian Ding
  • Patent number: 11423121
    Abstract: Methods and systems for performing real time digital content concealment are described herein. A computing device may, in response to detecting a user within view of an image capture device of a client device, perform a first type of text recognition on a first region of digital content and a second type of text recognition on a second region of the digital content, where the first type of text recognition is determined based on a first type of content items contained in the first region and the second type of text recognition is determined based on a second type of content items contained in the second region. Based at least in part on rules corresponding to the user, the computing device may determine content items within the digital content to be concealed, and may modify the digital content to conceal the content items.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: August 23, 2022
    Assignee: Citrix Systems, Inc.
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang
  • Publication number: 20220261300
    Abstract: In some implementations, a method may involve determining first feature vectors for a plurality of data items accessed by a user of one or more client devices, the first feature vectors representing first contextual data about the one or more client devices at times that respective data items of the plurality of data items were accessed, the plurality of data items including a first data item. A predictive model, configured to classify input feature vectors into context types, may be used to determine that the first feature vector for the first data item is classified as a first context type. A second feature vector representing second contextual data about a first client device operated by the user may be determined and the predictive model may be used to determined that the second feature vector is classified as the first context type.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Daowen Wei, Jian Ding, Hengbo Wang
  • Patent number: 11414913
    Abstract: A train door control method and system are provided. The train door control method includes: acquiring a first train identifier and a second train identifier when multiple trains park in a platform at the same time, a door of a first train to which the first train identifier belongs being to be opened at a current time point, and a second train to which the second train identifier belongs being a train arranged behind the first train, which enters the platform and parks in the platform; and controlling the opening and closing of the door of the first train and a door of the second train at different time points respectively according to the first train identifier and the second train identifier.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: August 16, 2022
    Assignee: BYD COMPANY LIMITED
    Inventors: Jian Ding, Faping Wang
  • Patent number: 11406651
    Abstract: The present invention relates to the application of mannuronic diacid oligosaccharide composition in the treatment of vascular dementia.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Xiaoguang Du, Zhenqing Zhang, Jian Ding
  • Patent number: 11406653
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of pain.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Zhenqing Zhang, Jian Ding
  • Patent number: 11406652
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of diabetes.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Zhenqing Zhang, Jian Ding
  • Patent number: 11406654
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of Parkinson's disease.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Xiaoguang Du, Zhenqing Zhang, Jian Ding